ORAL-CONTRACEPTIVES AND CORONARY HEART-DISEASE - MODULATION OF GLUCOSE-TOLERANCE AND PLASMA-LIPID RISK-FACTORS BY PROGESTINS

被引：48

作者：

CROOK, D

GODSLAND, IF

WYNN, V

机构：

来源：

关键词：

D O I：

10.1016/0002-9378(88)90199-8

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：1612 / 1620

页数：9

共 86 条

[1] Adams P W, 1980, J Pharmacother, V3, P54
[2] ALBERS JJ, 1984, CLIN METABOLIC ASPEC, P381
[3] ASSMANN G, 1982, LIPID METABOLISM ATH, P155
[4] BACHORIK PS, 1985, CLIN CHEM, V31, P1107
[5] HIGH-DENSITY AND LOW-DENSITY LIPOPROTEIN SUBFRACTIONS IN SURVIVORS OF MYOCARDIAL-INFARCTION AND IN CONTROL SUBJECTS
BALLANTYNE, FC
CLARK, RS
SIMPSON, HS
BALLANTYNE, D
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1982, 31 (05): : 433 - 437
[6] BARR DP, 1951, AM J MED, V11, P480, DOI 10.1016/0002-9343(51)90183-0
[7] BATZER FR, 1986, J REPROD MED, V31, P848
[8] BAYLISS R, 1987, J ROY COLL PHYS LOND, V21, P134
[9] CONTRACEPTIVE STEROIDS - MODIFICATIONS OF CARBOHYDRATE AND LIPID-METABOLISM
BECK, P
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1973, 22 (06): : 841 - 855
[10] ASSESSMENT OF INSULIN SENSITIVITY INVIVO
BERGMAN, RN
FINEGOOD, DT
ADER, M
[J]. ENDOCRINE REVIEWS, 1985, 6 (01) : 45 - 86